Grade 1 2 And 3 Meningioma clinical trials

Explore recruiting grade 1 2 and 3 meningioma clinical trials.

Also recruiting in Europe

Grade 1 2 And 3 Meningioma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Regorafenib for recurrent meningioma. A multicenter, randomized phase II study (MIRAGE trial)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Grade 1 2 And 3 Meningioma trials by city

Grade 1 2 And 3 Meningioma in Toronto Grade 1 2 And 3 Meningioma in Vancouver Grade 1 2 And 3 Meningioma in Montreal Grade 1 2 And 3 Meningioma in Calgary Grade 1 2 And 3 Meningioma in Edmonton Grade 1 2 And 3 Meningioma in Ottawa Grade 1 2 And 3 Meningioma in Winnipeg Grade 1 2 And 3 Meningioma in Quebec City Grade 1 2 And 3 Meningioma in Hamilton Grade 1 2 And 3 Meningioma in Kitchener Grade 1 2 And 3 Meningioma in London Grade 1 2 And 3 Meningioma in Halifax Grade 1 2 And 3 Meningioma in New York Grade 1 2 And 3 Meningioma in Los Angeles Grade 1 2 And 3 Meningioma in Chicago Grade 1 2 And 3 Meningioma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease